[Diagnosis and staging of malignant pleural mesothelioma].
Malignant pleural mesothelioma (MPM) is an aggressive solid tumor with rising incidence and mortality. Due to a long latency period after asbestos exposure until tumor manifestation the peak of newly diagnosed MPM cases is to be expected for the year 2017 in Germany. One deciding factor for the poor prognosis with a median survival of 4 - 18 month is a late diagnosis at an advanced stage. Therefore, apart of improved stage related therapeutic options, early diagnostic procedures in suspected MPM play a key role. The diagnosis of MPM is made by the clinician as a synopsis of clinical, imaging and pathological findings. Computed tomography of the thorax and thoracoscopy with biopsy are the most important diagnostic procedures. Staging is recommended to be made as TNM description according to the International Mesothelioma Interest Group (IMIG) to allow a better comparability of various data in MPM.
Sohrab
S
S
Ruhrlandklinik Essen, Abteilung Pneumologie, Universitätsklinik, Germany. sebastian.sohrab@ob.kamp.net
Konietzko
N
N
D006801:Humans; D008654:Mesothelioma / Q000175:diagnosis* / Q000473:pathology; D009367:Neoplasm Staging; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000473:pathology; D011379:Prognosis
Diagnostik und Stadieneinteilung des malignen Pleuramesothelioms.